Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DISHMAN PHARMA vs ALKEM LABORATORIES - Comparison Results

DISHMAN PHARMA     Change

Dishman Pharmaceuticals is involved in the manufacture of APIs (active pharmaceutical ingredients), intermediates, quaternary compounds and fine chemicals. Besides this, the company is a significant player in the CRAMS (Contract Research and Manufact... More

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DISHMAN PHARMA ALKEM LABORATORIES DISHMAN PHARMA/
ALKEM LABORATORIES
 
P/E (TTM) x 25.1 25.0 100.5% View Chart
P/BV x 3.3 6.0 55.6% View Chart
Dividend Yield % 0.7 0.8 82.5%  

Financials

 DISHMAN PHARMA   ALKEM LABORATORIES
EQUITY SHARE DATA
    DISHMAN PHARMA
Mar-16
ALKEM LABORATORIES
Mar-20
DISHMAN PHARMA/
ALKEM LABORATORIES
5-Yr Chart
Click to enlarge
High Rs3742,720 13.8%   
Low Rs1291,660 7.8%   
Sales per share (Unadj.) Rs197.8697.9 28.3%  
Earnings per share (Unadj.) Rs21.296.1 22.1%  
Cash flow per share (Unadj.) Rs34.7117.3 29.6%  
Dividends per share (Unadj.) Rs2.0025.00 8.0%  
Dividend yield (eoy) %0.81.1 69.6%  
Book value per share (Unadj.) Rs179.9515.2 34.9%  
Shares outstanding (eoy) m80.69119.57 67.5%   
Bonus/Rights/Conversions ---  
Price / Sales ratio x1.33.1 40.5%   
Avg P/E ratio x11.922.8 52.1%  
P/CF ratio (eoy) x7.218.7 38.8%  
Price / Book Value ratio x1.44.3 32.9%  
Dividend payout %9.426.0 36.3%   
Avg Mkt Cap Rs m20,306261,879 7.8%   
No. of employees `0000.814.3 5.8%   
Total wages/salary Rs m5,35515,055 35.6%   
Avg. sales/employee Rs Th19,252.75,822.6 330.7%   
Avg. wages/employee Rs Th6,459.51,050.5 614.9%   
Avg. net profit/employee Rs Th2,064.1802.0 257.4%   
INCOME DATA
Net Sales Rs m15,96183,444 19.1%  
Other income Rs m2651,042 25.5%   
Total revenues Rs m16,22684,486 19.2%   
Gross profit Rs m4,10314,734 27.8%  
Depreciation Rs m1,0912,528 43.1%   
Interest Rs m944651 145.2%   
Profit before tax Rs m2,33412,598 18.5%   
Minority Interest Rs m00-   
Prior Period Items Rs m10-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6241,105 56.4%   
Profit after tax Rs m1,71111,493 14.9%  
Gross profit margin %25.717.7 145.6%  
Effective tax rate %26.78.8 304.7%   
Net profit margin %10.713.8 77.8%  
BALANCE SHEET DATA
Current assets Rs m11,01854,960 20.0%   
Current liabilities Rs m9,51732,433 29.3%   
Net working cap to sales %9.427.0 34.8%  
Current ratio x1.21.7 68.3%  
Inventory Days Days11080 138.9%  
Debtors Days Days3572 48.3%  
Net fixed assets Rs m16,30432,710 49.8%   
Share capital Rs m161239 67.5%   
"Free" reserves Rs m12,90761,368 21.0%   
Net worth Rs m14,51661,607 23.6%   
Long term debt Rs m4,1891,592 263.1%   
Total assets Rs m29,80599,433 30.0%  
Interest coverage x3.520.4 17.0%   
Debt to equity ratio x0.30 1,116.6%  
Sales to assets ratio x0.50.8 63.8%   
Return on assets %8.912.2 73.0%  
Return on equity %11.818.7 63.2%  
Return on capital %17.521.0 83.6%  
Exports to sales %24.819.1 129.9%   
Imports to sales %3.73.0 125.6%   
Exports (fob) Rs m3,95615,917 24.9%   
Imports (cif) Rs m5962,483 24.0%   
Fx inflow Rs m4,95216,061 30.8%   
Fx outflow Rs m6972,483 28.1%   
Net fx Rs m4,25513,578 31.3%   
CASH FLOW
From Operations Rs m2,7865,851 47.6%  
From Investments Rs m-1,529-7,414 20.6%  
From Financial Activity Rs m-941792 -118.9%  
Net Cashflow Rs m316-731 -43.3%  

Share Holding

Indian Promoters % 61.4 66.9 91.8%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 3.7 33.1 11.2%  
FIIs % 12.7 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 22.1 0.0 -  
Shareholders   46,261 68,381 67.7%  
Pledged promoter(s) holding % 35.8 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DISHMAN PHARMA With:   AUROBINDO PHARMA  ORCHID PHARMA  JUBILANT LIFE SCIENCES  SHASUN PHARMA  PIRAMAL ENTERPRISES  

Compare DISHMAN PHARMA With:   ACTAVIS (US)  ADCOCK INGRAM (S. Africa)  MYLAN (US)  TEVA PHARMA (Israel)  



Today's Market

5 Reasons Why Sensex and Nifty Fell Over 1% Today(Closing)

Indian share markets witnessed heavy selling pressure today, pausing the record rally, with all sectors barring telecom, reeling under pressure.

Related Views on News

Most Popular

My Top Stock Recommendation for 2021 and Beyond(Profit Hunter)

Jan 5, 2021

My new guide will show you the huge potential in future proof businesses.

'Essential' Smallcap Stock Recommendations(Profit Hunter)

Jan 8, 2021

The smallcap rally has enough steam left in it. If you haven't joined yet, it is still not too late.

Is Nifty Forming a Top(Fast Profits Daily)

Jan 8, 2021

The charts are telling the bulls to be cautious.

Why Gold Hit Lower Circuit(Fast Profits Daily)

Jan 11, 2021

Were you shocked that bullion prices hit lower circuits on Friday on the MCX? Find out why it happened...

Five Wishes and a Will(The Honest Truth)

Jan 4, 2021

Ajit Dayal on the investing strategy for 2021 and beyond.

More

India's #1 Trader
Reveals His Secrets

Secret To Increasing Your Trading Profits Today
Get this Special Report,
The Secret to Increasing Your Trading Profits Today, Now!
We will never sell or rent your email id.
Please read our Terms

DISHMAN PHARMA SHARE PRICE


May 29, 2017 (Close)

TRACK DISHMAN PHARMA

  • Track your investment in DISHMAN PHARMA with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DISHMAN PHARMA

DISHMAN PHARMA 5-YR ANALYSIS

COMPARE DISHMAN PHARMA WITH

MARKET STATS